Huerta, J.L.; Kendall, R.; Ivkovic, L.; Molina, C.; Law, A.W.; Mendes, D.
Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico. Vaccines 2025, 13, 77.
https://doi.org/10.3390/vaccines13010077
AMA Style
Huerta JL, Kendall R, Ivkovic L, Molina C, Law AW, Mendes D.
Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico. Vaccines. 2025; 13(1):77.
https://doi.org/10.3390/vaccines13010077
Chicago/Turabian Style
Huerta, José Luis, Robyn Kendall, Luka Ivkovic, Carlos Molina, Amy W. Law, and Diana Mendes.
2025. "Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico" Vaccines 13, no. 1: 77.
https://doi.org/10.3390/vaccines13010077
APA Style
Huerta, J. L., Kendall, R., Ivkovic, L., Molina, C., Law, A. W., & Mendes, D.
(2025). Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico. Vaccines, 13(1), 77.
https://doi.org/10.3390/vaccines13010077
